|
P. aeruginosa infection; % (n)
|
42.9 (9)
|
52.4 (11)
|
0.758
|
|
MDR P. aeruginosa colonization; % (n)
|
100% (21)
|
42.9 (9)
|
<0.001
|
|
SAPS II total (95%Confidence Interval [CI])
|
50 (37–59)
|
44 (31–50)
|
0.147
|
|
Colonization site; % (n)
|
|
Tracheobronchial secretion
|
42.9 (9)
|
57.1 (12)
| |
|
Intraabdominal swab
|
9.5(2)
|
9.5 (2)
| |
|
Rectal
|
28.6 (6)
|
-
| |
|
Wound swab
|
9.5 (2)
|
-
| |
|
Urine
|
38.1 (8)
|
28.6 (6)
| |
|
Blood
|
-
|
4.8 (1)
| |
|
Stay in a room with colonized sink; % (n)
|
66.7 (14)
|
28.6 (6)
|
0.062a
|
|
Contact with MDR colonized patient; % (n)
|
14.3 (3)
|
-
| |
|
All drainages; % (n)
|
42.9 (9)
|
61.9 (13)
|
0.751
|
|
Dialysis or hemofiltration
|
33.3 (7)
|
4.8 (1)
|
0.045a
|
|
Gastric tube
|
95.2 (20)
|
85.7 (18)
|
0.606
|
|
Urinary catheter
|
100.0 (21)
|
100.0 (21)
|
1.000
|
|
Tracheal cannula
|
38.1 (8)
|
33.3 (7)
|
1.000
|
|
Central venous catheter
|
90.5 (19)
|
85.7 (18)
|
1.000
|
|
Leukopenia
|
14.3 (3)
|
14.3 (3)
|
1.000
|
|
Immunosuppression
|
38.1 (8)
|
9.5 (2)
|
0.067a
|
|
Septic chock
|
19.0 (4)
|
28.6 (6)
|
0.719
|
|
Surgery patient
|
85.7 (18)
|
90.5 (19)
|
1.000
|
|
Neurosurgery patient
|
14.3 (3)
|
23.8 (5)
|
0.697
|
|
Age (years)
|
71.0 (55.2–78.1)
|
75.5 (63.4–83.4)
|
0.120
|
|
LOS before colonization (days)
|
16 (11–34)
|
10 (5–28)
|
0.190
|
|
Length of stay overall (days)
|
38 (23–54)
|
30 (10–46)
|
0.170
|
|
Stay in single room (days)
|
0 (0–5)
|
0 (0–9)
|
1.000
|
|
Stay in shared room (days)
|
12 (6–30)
|
4 (0–16)
|
0.031a
|
|
Penicillin; % (n)
|
42.9 (9)
|
23.8 (5)
|
0.362
|
|
Cephalosporin; % (n)
|
42.9 (9)
|
23.8 (5)
|
0.362
|
|
Carbapenem; % (n)
|
42.9 (9)
|
28.6 (6)
|
0.520
|
|
Quinolone; % (n)
|
52.4 (11)
|
23.8 (5)
|
0.111
|
|
Aminoglycoside; % (n)
|
28.6 (6)
|
4.8 (1)
|
0.093a
|
|
Glycopeptide; % (n)
|
28.6 (6)
|
19.0 (4)
|
0.719
|
|
Antibiotic inhalation; % (n)
|
33.3 (7)
|
9.5 (2)
|
0.130
|
